The  	The  	 DT	O
Human  	Human  	 NNP	O
and  	and  	 CC	O
Economic  	Economic  	 NNP	B-NP
Burden  	Burden  	 NNP	I-NP
of  	of  	 IN	I-NP
Difficult-to-Treat  	Difficult-to-Treat  	 NNP	I-NP
Gouty  	Gouty  	 NNP	O
Arthritis  	Arthritis  	 NNP	O
Gouty  	Gouty  	 NNP	O
arthritis 	arthritis 	 NN	O
,  	,  	 ,	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
most  	most  	 RBS	O
painful  	painful  	 JJ	O
and  	and  	 CC	O
common  	common  	 JJ	O
forms  	forms  	 NNS	O
of  	of  	 IN	O
adult  	adult  	 NN	O
arthritis 	arthritis 	 NN	O
,  	,  	 ,	O
is  	is  	 VBZ	O
caused  	caused  	 VBN	O
by  	by  	 IN	O
monosodium  	monosodium  	 JJ	B-NP
urate  	urate  	 JJ	I-NP
crystal  	crystal  	 NN	I-NP
deposits  	deposits  	 NNS	I-NP
in  	in  	 IN	O
joints 	joints 	 NNS	O
,  	,  	 ,	O
most  	most  	 RBS	O
often  	often  	 RB	O
in  	in  	 IN	O
the  	the  	 DT	O
lower  	lower  	 JJR	O
extremities 	extremities 	 NN	O
.  	.  	 .	O
Crystals  	Crystals  	 NNS	O
trigger  	trigger  	 VBP	O
an  	an  	 DT	O
inflammatory  	inflammatory  	 JJ	B-NP
response  	response  	 NN	I-NP
leading  	leading  	 VBG	O
to  	to  	 TO	O
acute  	acute  	 VB	O
flares  	flares  	 VBN	O
characterized  	characterized  	 VBN	O
by  	by  	 IN	O
a  	a  	 DT	O
rapid  	rapid  	 JJ	B-NP
onset  	onset  	 NN	I-NP
of  	of  	 IN	O
pain 	pain 	 NN	O
,  	,  	 ,	O
warmth 	warmth 	 NN	B-NP
,  	,  	 ,	O
swelling 	swelling 	 VBG	O
,  	,  	 ,	O
and  	and  	 CC	O
redness  	redness  	 NN	O
in  	in  	 IN	O
involved  	involved  	 JJ	O
joints 	joints 	 NNS	O
.  	.  	 .	O
Over  	Over  	 IN	O
time 	time 	 NN	O
,  	,  	 ,	O
continued  	continued  	 VBD	O
monosodium  	monosodium  	 JJ	B-NP
urate  	urate  	 JJ	I-NP
crystal  	crystal  	 NN	I-NP
deposits  	deposits  	 NNS	I-NP
and  	and  	 CC	O
inflammation  	inflammation  	 NNS	B-NP
can  	can  	 MD	O
lead  	lead  	 VB	O
to  	to  	 TO	O
chronic  	chronic  	 VB	B-NP
tophaceous  	tophaceous  	 JJ	I-NP
gout  	gout  	 NN	I-NP
that  	that  	 IN	O
result  	result  	 NN	O
in  	in  	 IN	O
bone  	bone  	 NN	O
erosion 	erosion 	 NN	O
,  	,  	 ,	O
progressing  	progressing  	 VBG	O
to  	to  	 TO	O
joint  	joint  	 JJ	O
destruction  	destruction  	 NN	O
and  	and  	 CC	O
significant  	significant  	 JJ	O
disability 	disability 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
goal  	goal  	 NN	O
of  	of  	 IN	O
therapy  	therapy  	 NN	O
in  	in  	 IN	O
an  	an  	 DT	O
acute  	acute  	 JJ	O
gout  	gout  	 JJ	O
flare  	flare  	 NN	O
is  	is  	 VBZ	O
prompt  	prompt  	 JJ	O
and  	and  	 CC	O
safe  	safe  	 JJ	O
termination  	termination  	 NN	O
of  	of  	 IN	O
pain  	pain  	 NN	O
and  	and  	 CC	O
inflammation 	inflammation 	 NN	B-NP
.  	.  	 .	O
Acute  	Acute  	 JJ	O
gouty  	gouty  	 JJ	O
arthritis  	arthritis  	 NN	O
is  	is  	 VBZ	O
usually  	usually  	 RB	O
treated  	treated  	 VBN	O
with  	with  	 IN	O
nonsteroidal  	nonsteroidal  	 JJ	B-NP
anti-inflammatory  	anti-inflammatory  	 JJ	I-NP
drugs 	drugs 	 NNS	I-NP
,  	,  	 ,	O
colchicine 	colchicine 	 NN	B-NP
,  	,  	 ,	O
or  	or  	 CC	O
corticosteroids 	corticosteroids 	 NN	B-NP
.  	.  	 .	O
However 	However 	 RB	O
,  	,  	 ,	O
for  	for  	 IN	O
a  	a  	 DT	O
growing  	growing  	 VBG	O
number  	number  	 NN	O
of  	of  	 IN	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
current  	current  	 JJ	O
standard  	standard  	 JJ	O
treatments  	treatments  	 NNS	O
are  	are  	 VBP	O
ineffective  	ineffective  	 JJ	O
or  	or  	 CC	O
are  	are  	 VBP	O
contraindicated 	contraindicated 	 VBN	O
,  	,  	 ,	O
largely  	largely  	 RB	O
due  	due  	 JJ	O
to  	to  	 TO	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
comorbidities 	comorbidities 	 NN	B-NP
.  	.  	 .	O
Gouty  	Gouty  	 JJ	O
arthritis  	arthritis  	 NN	O
can  	can  	 MD	O
have  	have  	 VB	O
a  	a  	 DT	O
major  	major  	 JJ	O
negative  	negative  	 JJ	B-NP
impact  	impact  	 NN	I-NP
of  	of  	 IN	O
health-related  	health-related  	 JJ	O
quality  	quality  	 NN	O
of  	of  	 IN	O
life 	life 	 NN	O
,  	,  	 ,	O
especially  	especially  	 RB	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
difficult-to-treat  	difficult-to-treat  	 JJ	B-NP
disease 	disease 	 NN	I-NP
,  	,  	 ,	O
as  	as  	 RB	O
revealed  	revealed  	 VBN	O
by  	by  	 IN	O
recent  	recent  	 JJ	O
studies  	studies  	 NNS	O
comparing  	comparing  	 VBG	O
health-related  	health-related  	 JJ	O
quality  	quality  	 NN	O
of  	of  	 IN	O
life  	life  	 NN	O
with  	with  	 IN	O
that  	that  	 DT	O
of  	of  	 IN	O
the  	the  	 DT	O
general  	general  	 JJ	O
population 	population 	 NN	O
.  	.  	 .	O
Additionally 	Additionally 	 RB	O
,  	,  	 ,	O
gouty  	gouty  	 JJ	O
arthritis  	arthritis  	 NN	O
also  	also  	 RB	O
constitutes  	constitutes  	 VBZ	O
an  	an  	 DT	O
important  	important  	 JJ	O
economic  	economic  	 JJ	B-NP
burden  	burden  	 NN	I-NP
through  	through  	 IN	O
absence  	absence  	 NN	B-NP
from  	from  	 IN	O
work  	work  	 NN	O
and  	and  	 CC	O
medical  	medical  	 JJ	B-NP
costs 	costs 	 NNS	I-NP
.  	.  	 .	O
This  	This  	 DT	O
burden  	burden  	 NN	O
is  	is  	 VBZ	O
even  	even  	 RB	O
greater  	greater  	 JJR	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
with  	with  	 IN	O
difficult-to-treat  	difficult-to-treat  	 JJ	B-NP
disease 	disease 	 NN	I-NP
.  	.  	 .	O
